FREMONT, CA--(Marketwire - August 19, 2008) - Cardima, Inc. (OTCBB: CADM), a medical device company focused on the treatment of Atrial Fibrillation (“AF”) and manufacturer of the Cardima’s Surgical Ablation System and the EP Revelation® line of therapeutic catheters, has received approval from the Food and Drug Administration, Ministry of Public Health, in Thailand, to market its three main lines of products, including the diagnostic products, the EP therapeutic REVELATION line of products and the Surgical Ablation System.
